EQUINOX NEPREMICNINE d.d. (LJSE:EQNX)
62.00
+1.00 (1.64%)
At close: Jul 21, 2026
-3.13% (1Y)
| Market Cap | 108.84M -0.9% |
| Revenue (ttm) | 9.43M +1.5% |
| Net Income | 2.46M +71.3% |
| EPS | 1.38 |
| Shares Out | 1.78M |
| PE Ratio | 44.27 |
| Forward PE | n/a |
| Dividend | 1.83 (3.00%) |
| Ex-Dividend Date | Jun 18, 2026 |
| Volume | 2 |
| Open | 62.00 |
| Previous Close | 61.00 |
| Day's Range | 62.00 - 62.00 |
| 52-Week Range | 59.00 - 65.50 |
| Beta | 0.02 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Jul 24, 2026 |